Direct-to-consumer advertising (DTCA) is legal only in the United States and New Zealand and has been linked with drug overutilization, public health concerns, and higher costs.1 Despite global proscriptions, DTCA is the most rapidly increasing form of pharmaceutical marketing, with approximately $4 billion in US expenditures, outpacing physician marketing and research and development.2
Liang BA, Mackey T. Direct-to-Consumer Advertising With Interactive Internet Media: Global Regulation and Public Health Issues. JAMA. 2011;305(8):824–825. doi:10.1001/jama.2011.203
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: